292 related articles for article (PubMed ID: 21920241)
1. Melasma: a comprehensive update: part I.
Sheth VM; Pandya AG
J Am Acad Dermatol; 2011 Oct; 65(4):689-697. PubMed ID: 21920241
[TBL] [Abstract][Full Text] [Related]
2. Melasma pathogenesis: a review of the latest research, pathological findings, and investigational therapies.
Rajanala S; Maymone MBC; Vashi NA
Dermatol Online J; 2019 Oct; 25(10):. PubMed ID: 31735001
[TBL] [Abstract][Full Text] [Related]
3. Utilizing combination therapy to optimize melasma outcomes.
Rendon MI
J Drugs Dermatol; 2004; 3(5 Suppl):S27-34. PubMed ID: 15552597
[TBL] [Abstract][Full Text] [Related]
4. Melasma in men.
Vachiramon V; Suchonwanit P; Thadanipon K
J Cosmet Dermatol; 2012 Jun; 11(2):151-7. PubMed ID: 22672280
[TBL] [Abstract][Full Text] [Related]
5. Melasma: Updates and perspectives.
Kwon SH; Na JI; Choi JY; Park KC
Exp Dermatol; 2019 Jun; 28(6):704-708. PubMed ID: 30422338
[TBL] [Abstract][Full Text] [Related]
6. Q-switched alexandrite laser-assisted treatment of melasma: 2-year follow-up monitoring.
Rusciani A; Motta A; Rusciani L; Alfano C
J Drugs Dermatol; 2005; 4(6):770-4. PubMed ID: 16302566
[TBL] [Abstract][Full Text] [Related]
7. [Melasma : An update on the clinical picture, treatment, and prevention].
Becker S; Schiekofer C; Vogt T; Reichrath J
Hautarzt; 2017 Feb; 68(2):120-126. PubMed ID: 28084498
[TBL] [Abstract][Full Text] [Related]
8. Histopathological comparison of lesional and perilesional skin in melasma: A cross-sectional analysis.
Gautam M; Patil S; Nadkarni N; Sandhu M; Godse K; Setia M
Indian J Dermatol Venereol Leprol; 2019; 85(4):367-373. PubMed ID: 30516167
[TBL] [Abstract][Full Text] [Related]
9. The treatment of melasma: a review of clinical trials.
Gupta AK; Gover MD; Nouri K; Taylor S
J Am Acad Dermatol; 2006 Dec; 55(6):1048-65. PubMed ID: 17097400
[TBL] [Abstract][Full Text] [Related]
10. Hyperpigmentation and melasma.
Rigopoulos D; Gregoriou S; Katsambas A
J Cosmet Dermatol; 2007 Sep; 6(3):195-202. PubMed ID: 17760699
[TBL] [Abstract][Full Text] [Related]
11. Melasma.
Wu IB; Lambert C; Lotti TM; Hercogová J; Sintim-Damoa A; Schwartz RA
G Ital Dermatol Venereol; 2012 Aug; 147(4):413-8. PubMed ID: 23007216
[TBL] [Abstract][Full Text] [Related]
12. Melasma: a review.
Victor FC; Gelber J; Rao B
J Cutan Med Surg; 2004; 8(2):97-102. PubMed ID: 15685388
[TBL] [Abstract][Full Text] [Related]
13. Melasma and assessment of the quality of life in Brazilian women.
Ikino JK; Nunes DH; Silva VP; Fröde TS; Sens MM
An Bras Dermatol; 2015; 90(2):196-200. PubMed ID: 25830989
[TBL] [Abstract][Full Text] [Related]
14. Solar elastosis and presence of mast cells as key features in the pathogenesis of melasma.
Hernández-Barrera R; Torres-Alvarez B; Castanedo-Cazares JP; Oros-Ovalle C; Moncada B
Clin Exp Dermatol; 2008 May; 33(3):305-8. PubMed ID: 18419607
[TBL] [Abstract][Full Text] [Related]
15. Melasma: How hormones can modulate skin pigmentation.
Filoni A; Mariano M; Cameli N
J Cosmet Dermatol; 2019 Apr; 18(2):458-463. PubMed ID: 30779300
[TBL] [Abstract][Full Text] [Related]
16. Future therapies in melasma: What lies ahead?
Sarkar R; Bansal A; Ailawadi P
Indian J Dermatol Venereol Leprol; 2020; 86(1):8-17. PubMed ID: 31793496
[TBL] [Abstract][Full Text] [Related]
17. Melasma pathogenesis and influencing factors - an overview of the latest research.
Passeron T
J Eur Acad Dermatol Venereol; 2013 Jan; 27 Suppl 1():5-6. PubMed ID: 23205539
[TBL] [Abstract][Full Text] [Related]
18. Recent progress in melasma pathogenesis.
Lee AY
Pigment Cell Melanoma Res; 2015 Nov; 28(6):648-60. PubMed ID: 26230865
[TBL] [Abstract][Full Text] [Related]
19. Melasma’s Impact on Quality of Life.
Kagha K; Fabi S; Goldman MP
J Drugs Dermatol; 2020 Feb; 19(2):184-187. PubMed ID: 32129968
[TBL] [Abstract][Full Text] [Related]
20. Melasma in Latin Americans.
Perez M; Luke J; Rossi A
J Drugs Dermatol; 2011 May; 10(5):517-23. PubMed ID: 21533299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
